Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate vs remazolam tosylate for hemodynamic stability in elderly general anesthesia induction
ChiCTR2100042870Phase 4Recruiting
- Sponsor
- Chenzhou First People's Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial comparing Group R – remazolam tosylate with Group E – etomidate (2 arms). Primary endpoints: blood pressure and heart rate. Started Jul 2020; status: recruiting.
02
Drugs
remimazolametomidate
Beyond the preview
Go deeper on ChiCTR2100042870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042870.